针灸治疗抑郁症有效性与安全性的系统评价再评价
该研究汇总31项荟萃分析(含59项随机对照试验),评估针灸治疗抑郁症的疗效与安全性。结果显示针灸在减轻抑郁严重程度方面可能优于不治疗、对照针灸及抗抑郁药,且不良事件更少,但纳入荟萃分析的方法学质量低或极低,证据强度多为低至极低。
要点
- 针灸可能小幅减轻抑郁严重程度,优于不治疗、对照针灸及抗抑郁药。
- 针灸联合抗抑郁药可能优于单用抗抑郁药。
- 针灸不良事件发生率可能低于抗抑郁药。
核心结论
- 针灸可能比不治疗、对照针灸及抗抑郁药更有效且更安全,但现有证据质量极低,需更严谨的主研究证实。
研究设计与样本
- 检索3个国际和3个中文数据库至2019年8月的随机试验荟萃分析,最终纳入31项荟萃分析(含59项随机对照试验)。
- 采用AMSTAR-2评估方法学质量,GRADE评估证据强度。
主要发现
- 针灸 vs 不治疗/等待/常规治疗:SMD -0.74(95% CI -1.06至-0.41),8项试验,624例。
- 针灸 vs 对照针灸(侵入性或非侵入性假对照):SMD 0.27(95% CI -0.51至-0.04),20项试验,1055例。
- 针灸 vs 抗抑郁药(SSRI/TCAs):SMD -0.28(95% CI -0.46至-0.10),30项试验,3068例。
- 针灸联合抗抑郁药 vs 抗抑郁药(SSRI/TCAs):SMD -0.99(95% CI -1.37至-0.61),17项试验,1110例。
- 亚组分析:电针与侵入性对照(P=0.37)、电针与非侵入性对照(P=0.90)、手针与四环类抗抑郁药(P=0.57)、电针与四环类抗抑郁药(P=0.07)均无差异。
关键数值与推荐
- 6项荟萃分析结论认为针灸相比抗抑郁药可减少不良事件发生率。
- AMSTAR-2评价显示纳入荟萃分析质量低或极低。
- GRADE评价显示大多数结局的证据强度为低至极低。
临床怎么用
- 针灸可考虑作为抑郁症的辅助或替代治疗选择,但需向患者说明证据质量极低。
- 临床决策应结合患者偏好及具体抗抑郁药类型,并监测不良事件。
局限性
- 纳入荟萃分析方法学质量低或极低,证据强度多为低至极低。
- 原始研究异质性及结果矛盾可能影响结论可靠性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To provide an overview of existing meta-analysis (MAs) on the efficacy and safety of acupuncture for depression, and assess the methodological quality and the strength of evidence of the included MAs. METHODS: We searched MAs of randomized trials that have evaluated the effects of acupuncture on depression in three international and three Chinese databases from their inception until August 2019. The methodological quality of included MAs was evaluated with the Assessing the Methodological Quality of Systematic Reviews 2 (AMSTAR-2), and the strength of evidence with the Grading of Recommendations, Assessment, Development and Evaluation (GRADE). We used the intra-class correlation coefficient (ICC) to assess reviewer agreement in the pre-experiment. RESULTS: We included 31 MAs and 59 RCTs. The results of included MAs were conflicting, our meta-analyses found that acupuncture may confer small benefit in reducing the severity of depression by end of treatment than no treatment/wait list/treatment as usual(SMD -0.74, 95% CI -1.06 to -0.41, eight trials, 624 participants), control acupuncture (invasive, non-invasive sham controls) (SMD 0.27, 95% CI -0.51 to -0.04, 20 trials, 1055 participants), antidepressants(Selective serotonin reuptake inhibitors (SSRI)/ Tetracyclic antidepressants(TCAs)) (SMD -0.28, 95% CI -0.46 to -0.10, 30 trials, 3068 participants), acupuncture plus antidepressants versus antidepressants(SSRI/TCAs) (SMD -0.99, 95% CI -1.37 to -0.61, 17 trials, 1110 participants). Subgroup analyses showed that there was no difference between electro-acupuncture and invasive control (P = 0.37), electro-acupuncture and non-invasive control (P = 0.90), manual acupuncture and Tetracyclic antidepressants (P = 0.57), electro-acupuncture and Tetracyclic antidepressants (P = 0.07). Six MAs concluded that acupuncture reduced the incidence of adverse events compared with antidepressants. The evaluation with AMSTAR-2 showed that the quality of included MAs was low or critically low. The results of the GRADE evaluation showed that the strength of evidence was low to very low for most outcomes. CONCLUSIONS: Although acupuncture appears to be more effective and safer than no treatment, control acupuncture and antidepressants, the quality of the available evidence was very low. Further methodologically rigorous and adequately powered primary studies are needed to confirm the effectiveness of acupuncture for depression.
引用
- Li M, Niu J, Yan P, et al. The effectiveness and safety of acupuncture for depression: An overview of meta-analyses. Complement Ther Med. 2019. PMID: 32444032. doi:10.1016/j.ctim.2019.102202
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。